Ten Years of Complete Remission of Pulmonary Metastasis after Post-Cystectomy Palliative Cisplatin-Gemcitabine Chemotherapy with Gefitinib for Muscle Invasive Bladder Cancer: A Case Report

2016 ◽  
Vol 97 (4) ◽  
pp. 485-488 ◽  
Author(s):  
Omar Fahmy ◽  
Marcus Scharpf ◽  
Tina Schubert ◽  
Susan Feyerabend ◽  
Arnulf Stenzl ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
Case Report ◽  
Complete Remission ◽  
Pulmonary Metastasis ◽  
Invasive Bladder Cancer ◽  
Muscle Invasive Bladder Cancer ◽  
Muscle Invasive

scholarly journals Metastatic non-muscle invasive bladder cancer with meningeal carcinomatosis: case report of an unexpected response

BMC Cancer ◽  
2017 ◽  
Vol 17 (1) ◽  
Author(s):  
Diego Teyssonneau ◽  
Amaury Daste ◽  
Vincent Dousset ◽  
Jean-Luc Hoepffner ◽  
Alain Ravaud ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
Case Report ◽  
Meningeal Carcinomatosis ◽  
Invasive Bladder Cancer ◽  
Muscle Invasive Bladder Cancer ◽  
Muscle Invasive

scholarly journals Non-muscle invasive bladder cancer with prostatic stroma invasion: A case report and review of literature

2015 ◽  
Vol 26 (2) ◽  
pp. S66
Author(s):  
Chu-Wen Fang ◽  
Mon-I. Yen ◽  
Bai-Fu Wang ◽  
Jian-Ting Chen ◽  
You-Chiuan Chien
Keyword(s):  
Bladder Cancer ◽  
Case Report ◽  
Invasive Bladder Cancer ◽  
Review Of Literature ◽  
Muscle Invasive Bladder Cancer ◽  
Muscle Invasive

scholarly journals Delayed Local Recurrence Following Radiation Therapy for Muscle-Invasive Bladder Cancer Emphasizing the Need for Lifelong Surveillance: a Case Report

2008 ◽  
Vol 8 ◽  
pp. 166-168
Author(s):  
Rajitha Sunkara ◽  
Rajinikanth Ayyathurai ◽  
Alan Nieder ◽  
Murugesan Manoharan
Keyword(s):  
Bladder Cancer ◽  
Radiation Therapy ◽  
Case Report ◽  
Local Recurrence ◽  
Radiation Treatment ◽  
Post Treatment ◽  
Invasive Bladder Cancer ◽  
Muscle Invasive Bladder Cancer ◽  
Muscle Invasive

We report a case of 68-years-old gentleman who developed a delayed local recurrence, 30 years following curative radiation treatment for muscle-invasive bladder cancer. This case emphasizes the importance of lifelong post-treatment surveillance for bladder cancer.

scholarly journals EP-1804: Laparoscopic robot-assisted brachytherapy of muscle-invasive bladder cancer: clinical case report

2017 ◽  
Vol 123 ◽  
pp. S990-S991
Author(s):  
F. Mascarenhas ◽  
F. Marques ◽  
K. Maes ◽  
R. Formoso ◽  
T. Antunes ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
Case Report ◽  
Clinical Case ◽  
Invasive Bladder Cancer ◽  
Robot Assisted ◽  
Muscle Invasive Bladder Cancer ◽  
Muscle Invasive

Ablative Intravesical Chemotherapy for Small Recurrent Non-Muscle-Invasive Bladder Cancer: A Prospective Study

2015 ◽  
Vol 96 (1) ◽  
pp. 14-19 ◽  
Author(s):  
Karel Decaestecker ◽  
Nicolaas Lumen ◽  
Annelies Ringoir ◽  
Willem Oosterlinck
Keyword(s):  
Bladder Cancer ◽  
Complete Remission ◽  
Intravesical Chemotherapy ◽  
Invasive Bladder Cancer ◽  
Muscle Invasive Bladder Cancer ◽  
Disease Free Interval ◽  
Free Interval ◽  
Muscle Invasive ◽  
A Prospective Study ◽  
Disease Free

Objective: The efficacy of intravesical chemotherapy in abolishing small papillary recurrences of non-muscle-invasive bladder cancer (NMIBC), the disease-free interval in responders and patients' preferences were explored. Methods: When a small (≤1 cm) papillary recurrence of a NMIBC was diagnosed, the patient could choose between immediate transurethral resection of the bladder (TURB) or four weekly intravesical instillations with mitomycin C (MMC) or epirubicin (ERC). Control cystoscopy was scheduled 2-3 weeks after the last instillation. Complete remission was defined as total disappearance of all papillary tumours and negative cytology. Results: 25 patients with 47 recurrence episodes were recruited from February 2003 until August 2011. The median follow-up was 35 months. After exclusion of 2 patients with intolerance to the instillations, 45 study episodes could be analysed. All patients to whom this was proposed preferred the instillations over immediate TURB. Complete, partial and no response was seen in 23 (51%), 6 (13%) and 16 (36%) out of 45 episodes, respectively. The median disease-free interval after complete remission was 16 months (95% confidence interval 9-24). Conclusions: Small papillary recurrences of NMIBC completely disappear in about half of the cases receiving four weekly bladder instillations with MMC or ERC. This is followed by a disease-free interval. Intravesical chemotherapy was preferred by all patients over immediate TURB.

Sign in / Sign up

Export Citation Format

Share Document